Mictonorm

Propiverine Hydrochloride, the active ingredient in Mictonorm, is an antimuscarinic (anticholinergic) presented as an oral tablet for oral use. It reduces involuntary detrusor muscle contractions, thereby alleviating symptoms of overactive bladder such as urgency, frequency, and urge urinary incontinence in adult patients. It is indicated for patients who experience bothersome urinary urgency and frequency that affect daily activities.

GNH USA supplies Mictonorm as a licensed, GDP‑compliant international pharmaceutical product, providing reliable sourcing to hospitals, pharmacies, and clinics worldwide through established distribution networks and quality‑assured manufacturing practices and regulatory compliance.

Propiverine Hydrochloride is an antimuscarinic agent used to manage symptoms of overactive bladder.

- Overactive bladder: reduces urgency, frequency and urge incontinence episodes. - Urinary urgency: provides relief from sudden, compelling need to void. - Urinary frequency: decreases the number of daily voids. - Urge urinary incontinence: helps control involuntary leakage.

Common Side Effects: - Dry mouth - Constipation - Blurred vision - Headache

Serious or Rare Side Effects: - Urinary retention - Severe allergic reaction (anaphylaxis) - Angle‑closure glaucoma

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in patients with severe impairment. - Review cardiac history: monitor for tachycardia or arrhythmias. - Evaluate for glaucoma: avoid in patients with narrow‑angle glaucoma. - Avoid concomitant anticholinergics: risk of additive anticholinergic effects. - Monitor for urinary retention: discontinue if significant retention occurs. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Propiverine may interact with other medicines as follows:

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase plasma levels. - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce efficacy. - Other anticholinergic drugs (e.g., tricyclic antidepressants): additive anticholinergic burden.

Moderate Interactions (Monitor Closely): - Diuretics: risk of dehydration and increased anticholinergic side effects. - Beta‑blockers: possible additive effect on heart rate. - Antihistamines: may enhance anticholinergic adverse events.